LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

JPMORGAN CHASE & CO's Holding History (CIK: 0000019617)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 194,651 Value ($000) $105 Avg Close — Range —
Q4 2024
Shares 433,265 Value ($000) $277 Avg Close — Range —
Q3 2024
Shares 96,749 Value ($000) $134 Avg Close — Range —
Q2 2024
Shares 97,143 Value ($000) $141 Avg Close — Range —
Q1 2024
Shares 654,622 Value ($000) $1,460 Avg Close — Range —
Q4 2023
Shares 162,594 Value ($000) $315 Avg Close — Range —
Q3 2023
Shares 254,461 Value ($000) $374 Avg Close — Range —
Q2 2023
Shares 235,375 Value ($000) $748 Avg Close — Range —
Q1 2023
Shares 625,007 Value ($000) $1,475 Avg Close — Range —
Q4 2022
Shares 572,147 Value ($000) $2 Avg Close — Range —
Q3 2022
Shares 519,992 Value ($000) $3,812 Avg Close — Range —
Q2 2022
Shares 527,174 Value ($000) $3,437 Avg Close — Range —
Q1 2022
Shares 518,404 Value ($000) $2,618 Avg Close — Range —
Q4 2021
Shares 464,351 Value ($000) $3,594 Avg Close — Range —
Q3 2021
Shares 342,072 Value ($000) $5,063 Avg Close — Range —